Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2003
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/18/2003CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003CA2486362A1 Novel recombinant anticoagulant proteins
12/18/2003CA2483555A1 Gamma lactams as prostaglandin agonists and use thereof
12/17/2003EP1371647A2 Pyridine-3-carboxylic acid derivatives and their use as intermediates
12/17/2003EP1371645A1 Process for the preparation of the 2'-(R)-Glycopyrronium Enantiomers and their use in medicaments
12/17/2003EP1371289A1 Choline-silicic acid complex
12/17/2003EP1370685A2 Diagnosis of diseases associated with dna repair
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89)
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370583A1 Polypeptides and nucleic acids for bolekine
12/17/2003EP1370561A2 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders
12/17/2003EP1370560A1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
12/17/2003EP1370559A1 Triazolopyridines as anti-inflammatory agents
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370553A2 Rho-kinase inhibitors
12/17/2003EP1370552A2 Rho-kinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1370518A2 Tryptase-inhibitors
12/17/2003EP1370297A2 Method and composition
12/17/2003EP1370279A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
12/17/2003EP1370276A2 Medical uses of intercellular communication facilitating compounds
12/17/2003EP1370268A2 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
12/17/2003EP1370266A1 Method of treatment
12/17/2003EP1370256A1 Novel inhibitors of formation of advanced glycation endproducts (ages)
12/17/2003EP1272470B1 Amorphous torasemide modification
12/17/2003EP1226131B1 Isoxazolecarboxamide derivatives
12/17/2003EP1224210B1 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1162970B1 Anti-inflammatory uses of manzamines
12/17/2003EP1147121B1 Ketolide antibiotics
12/17/2003EP1009420B1 Conjugates useful in the treatment of prostate cancer
12/17/2003EP1000047B1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring
12/17/2003EP0571387B1 A non-mitogenic competitive hgf antagonist
12/17/2003CN1462269A Fused azepine drivatives and their use as antidiuretic agents
12/16/2003US6664385 Kidney injury-related molecules
12/16/2003US6664249 Bicyclic vasopressin agonists
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
12/16/2003US6663900 Processed in a fluidized bed coating machine where a protective coating of a sugar or polyhydric alcohol, starch
12/16/2003CA2093125C Angiotensin ii antagonists
12/11/2003WO2003102593A1 Methods for avoiding renal injury
12/11/2003WO2003102138A2 Elongase genes and uses thereof
12/11/2003WO2003101991A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003WO2003101984A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101978A1 Phenyl-thiophene type vitamin d receptor modulators
12/11/2003WO2003101970A1 Imidazolium cxcr3 inhibitors
12/11/2003WO2003101964A1 Piperidine derivative, process for producing the same, and use
12/11/2003WO2003101959A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases
12/11/2003WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003WO2003101456A1 Use of compounds that stimulate cgmp
12/11/2003WO2003101450A1 N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris
12/11/2003WO2003101439A1 Medicament containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol in different formulations for treating urinary incontinence
12/11/2003WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof
12/11/2003WO2003080630A3 Phosphate transport inhibitors
12/11/2003WO2003053163A3 Salt composition with low sodium chloride and high organic potassium salt content and uses thereof
12/11/2003WO2003044053A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
12/11/2003WO2003026579A3 Combination therapies for immune mediated diseases
12/11/2003WO2003026564A3 Pharmaceutical compositions for the treatment of urinary disorders
12/11/2003WO2003024395A3 Linked biaryl compounds
12/11/2003WO2002094176A3 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments
12/11/2003WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
12/11/2003WO2002087465A3 Compositions and methods of double-targeting virus infections and cancer cells
12/11/2003US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/11/2003US20030229130 Imidazolinylmethyl aralkylsulfonamides
12/11/2003US20030229110 Cell signal transduction
12/11/2003US20030229104 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines
12/11/2003US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
12/11/2003US20030229080 Cardiovascular disorders; sexual disorders
12/11/2003US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003CA2487905A1 Use of cgmp - stimulating compounds
12/11/2003CA2487688A1 Piperidine derivative, process for producing the same, and use
12/11/2003CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003CA2486174A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/10/2003EP1369419A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
12/10/2003EP1369416A1 Stable crystals of pyrrole compound
12/10/2003EP1369414A1 Enantiomerically pure Arylcycloalkyl hydroxycarboxylic esters, processes for their preparation and their use as modulators of muscarinic receptors
12/10/2003EP1369119A1 Il-12 expression controlling agents
12/10/2003EP1368660A2 Assay
12/10/2003EP1368648A2 Detection of compounds that modulate inflammatory responses
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368357A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1368354A1 Modulators of chemokine receptor activity
12/10/2003EP1368353A1 2-alkoxyphenyl substituted imidazotriazinones
12/10/2003EP1368345A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists
12/10/2003EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
12/10/2003EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/10/2003EP1368317A1 Tryptase inhibitors
1 ... 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 ... 562